← All Okyo Pharma LTD filings

Okyo Pharma LTD Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
OKYO
Okyo Pharma LTD
4/A: OKYO Pharma Director Buys Shares
John P Brancaccio, a Director of OKYO Pharma Ltd, purchased 5,000 shares of common stock on July 21, 2026 for $1.48 per share.
NASDAQ
OKYO
Okyo Pharma LTD
4/A: OKYO Pharma CEO Buys Shares
Robert John Dempsey, CHIEF EXECUTIVE OFFICER and a Director of OKYO Pharma Ltd, purchased 15,000 shares of common stock on July 22, 2026 for $1.54 per share.
NASDAQ
OKYO
Okyo Pharma LTD
4/A: OKYO Pharma Executive Buys Shares
Gary S Jacob, CHIEF DEVELOPMENT OFFICER and a Director of OKYO Pharma Ltd, purchased 3,500 shares of common stock on July 21, 2026 for $1.40 per share.
NASDAQ
OKYO
Okyo Pharma LTD
4/A: OKYO Pharma Director Buys Shares
Gabriele M Cerrone, a Director and 10% owner of OKYO Pharma Ltd, purchased 22,500 shares of common stock on July 21, 2026 for $1.45 per share.
NASDAQ
OKYO
Okyo Pharma LTD
4/A: OKYO Pharma Director Buys Shares
Gabriele M Cerrone, a Director and 10% owner of OKYO Pharma Ltd, purchased 25,000 shares of common stock on July 20, 2026 for $1.40 per share.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: OKYO Pharma Executive Receives Stock Grant
Rajkumar Patil V., Chief Scientific Officer of OKYO Pharma Ltd, received 3,363 shares of common stock on July 27, 2026.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: OKYO Pharma CEO Receives Stock Grant
Robert John Dempsey, CHIEF EXECUTIVE OFFICER and a Director of OKYO Pharma Ltd, received 15,000 shares of common stock on July 22, 2026.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: OKYO Pharma Director Receives Stock Grant
Gabriele M Cerrone, a Director and 10% owner of OKYO Pharma Ltd, received 22,500 shares of common stock on July 21, 2026.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: OKYO Pharma Executive Receives Stock Grant
Gary S Jacob, CHIEF DEVELOPMENT OFFICER and a Director of OKYO Pharma Ltd, received 3,500 shares of common stock on July 21, 2026.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: OKYO Pharma Director Receives Stock Grant
John P Brancaccio, a Director of OKYO Pharma Ltd, received 5,000 shares of common stock on July 21, 2026.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: OKYO Pharma Executive Receives Stock Grant
Flavio Mantelli, CHIEF MEDICAL OFFICER of OKYO Pharma Ltd, received 20,000 shares of common stock on July 21, 2026.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: OKYO Pharma Director Receives Stock Grant
Gabriele M Cerrone, a Director and 10% owner of OKYO Pharma Ltd, received 25,000 shares of common stock on July 20, 2026.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: OKYO Pharma Director Acquires Shares
Bernard Denoyer, a Director at OKYO Pharma Ltd, acquired 3,500 shares through the exercise of options.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: OKYO Pharma Director Acquires Options
John P. Brancaccio, a Director at OKYO Pharma Ltd, acquired 6,500 stock options with an exercise price of $1.85, vesting over four years.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: OKYO Pharma Director Reports Stock Option Grant
OKYO Pharma Ltd. director Willy Simon reported the acquisition of stock options, indicating a vested interest in the company's future performance.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: OKYO Pharma Ltd: CFO Acquires Options
OKYO Pharma Ltd's Chief Financial Officer, Keeren Shah, acquired 40,000 stock options.
NASDAQ
OKYO
Okyo Pharma LTD
Form 4: Gabriele Cerrone Increases Stake in OKYO Pharma
Director and 10% owner Gabriele M. Cerrone acquired 300,000 shares of OKYO Pharma Ltd common stock at $1.72 per share.